Bank of Nova Scotia’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.8M Buy
203,318
+201,463
+10,861% +$30.6M 0.06% 203
2025
Q1
$279K Sell
1,855
-3,156
-63% -$475K ﹤0.01% 881
2024
Q4
$925K Buy
5,011
+232
+5% +$42.8K ﹤0.01% 778
2024
Q3
$941K Buy
4,779
+1,744
+57% +$344K ﹤0.01% 762
2024
Q2
$627K Sell
3,035
-2,060
-40% -$426K ﹤0.01% 811
2024
Q1
$1.38M Buy
5,095
+727
+17% +$197K ﹤0.01% 726
2023
Q4
$1.03M Buy
4,368
+1,734
+66% +$410K ﹤0.01% 768
2023
Q3
$516K Buy
2,634
+513
+24% +$101K ﹤0.01% 792
2023
Q2
$446K Sell
2,121
-1,402
-40% -$295K ﹤0.01% 838
2023
Q1
$711K Sell
3,523
-624
-15% -$126K ﹤0.01% 780
2022
Q4
$904K Sell
4,147
-40
-1% -$8.72K ﹤0.01% 825
2022
Q3
$824K Buy
4,187
+2
+0% +$394 ﹤0.01% 833
2022
Q2
$896K Sell
4,185
-36,991
-90% -$7.92M ﹤0.01% 863
2022
Q1
$11.7M Buy
41,176
+31,585
+329% +$8.97M 0.02% 412
2021
Q4
$3.62M Buy
9,591
+1,188
+14% +$448K 0.01% 742
2021
Q3
$3.47M Buy
8,403
+703
+9% +$290K 0.01% 683
2021
Q2
$2.85M Buy
+7,700
New +$2.85M 0.01% 692
2021
Q1
Sell
-44,189
Closed -$11M 1032
2020
Q4
$11M Buy
44,189
+4,216
+11% +$1.05M 0.02% 347
2020
Q3
$9.05M Sell
39,973
-29,795
-43% -$6.75M 0.02% 356
2020
Q2
$12.2M Buy
69,768
+30,770
+79% +$5.36M 0.04% 273
2020
Q1
$4.92M Sell
38,998
-43,347
-53% -$5.47M 0.02% 428
2019
Q4
$12.6M Sell
82,345
-50,004
-38% -$7.64M 0.03% 353
2019
Q3
$17.5M Buy
132,349
+121,089
+1,075% +$16M 0.05% 285
2019
Q2
$1.6M Buy
11,260
+260
+2% +$36.9K 0.01% 646
2019
Q1
$1.6M Sell
11,000
-39,100
-78% -$5.68M 0.01% 656
2018
Q4
$5.67M Buy
+50,100
New +$5.67M 0.03% 365
2014
Q2
Sell
-145,000
Closed -$8.75M 569
2014
Q1
$8.75M Buy
+145,000
New +$8.75M 0.04% 164